Evaluation Of Gc Ms, And Anti-Inflammatory Activity Of One Ayurveda Oil, Balahatadi Tailam
DOI:
https://doi.org/10.52783/jns.v14.3105Keywords:
Balahatadi tailam. GC-MS, 15-Hydroxypentadecanoic acid, cis-13-Octadecenoic acid, trans-13-Octadecenoic acidAbstract
This study investigates the therapeutic efficiency of Balahatadi Tailam, an Ayurvedic oil formulation renowned for its historical use in the management of medical conditions such as vertigo, migraines, and insomnia. The formulation has garnered attention in traditional medicine for its multifaceted healing properties, but scientific evidence supporting its efficacy has remained sparse. To bridge this gap, the present research explores the pharmacological profile of Balahatadi Tailam through a comprehensive analysis of its chemical composition using Gas Chromatography-Mass Spectrometry (GC-MS). The analysis revealed the presence of several bioactive compounds, including 15-Hydroxypentadecanoic acid, trans-13-Octadecenoic acid, β-Eudesmol, trimethylsilyl ether, N-Methyl-1-adamantane acetamide, and γ-Sitosterol. These compounds are known for their diverse pharmacological properties, including anti-inflammatory, antioxidant, and neuroprotective effects. The study highlights the cytoprotective and therapeutic potential of Balahatadi Tailam's active components, suggesting that it may play a significant role in alleviating conditions like vertigo, migraines, and insomnia by modulating the physiological pathways implicated in these disorders. This research underscores the value of integrating Ayurvedic practices with contemporary scientific approaches, showcasing how traditional formulations can contribute to modern therapeutic applications. By scientifically investigating the pharmacodynamics of Balahatadi Tailam, this study reinforces the growing relevance of Ayurvedic medicine in the development of alternative treatment strategies.
Downloads
Metrics
References
Patwardhan, B., Warude, D., Pushpangadan, P., & Bhatt, N. (2005). Ayurveda and traditional Chinese medicine: a comparative overview. Evidence‐Based Complementary and Alternative Medicine, 2(4), 465-473.
Sharma, H., Chandola, H. M., Singh, G., & Basisht, G. (2007). Utilization of Ayurveda in health care: an approach for prevention, health promotion, and treatment of disease. Part 2—Ayurveda in primary health care. The journal of alternative and complementary medicine, 13(10), 1135-1150.
Mukherjee, P. K., Harwansh, R. K., Bahadur, S., Banerjee, S., Kar, A., Chanda, J., ... & Katiyar, C. K. (2017). Development of Ayurveda–tradition to trend. Journal of ethnopharmacology, 197, 10-24.
Javed, H., Meeran, M. N., Azimullah, S., Bader Eddin, L., Dwivedi, V. D., Jha, N. K., & Ojha, S. (2020). α-Bisabolol, a dietary bioactive phytochemical attenuates dopaminergic neurodegeneration through modulation of oxidative stress, neuroinflammation and apoptosis in rotenone-induced rat model of Parkinson’s disease. Biomolecules, 10(10), 1421.
Prabhu, K, Mudiganti Ram Krishna Rao, A. K. Bharath, S. K. Vishal, Penna Balakrishna, Aparna Ravi, and J. Kalaivannan. The GC MS study of one Ayurvedic Rasayana formulation Narasimha Rasayanam. DIT, 2020; 13(5): 658-662
Anyasor GN, Okanlawon AA, Ogunbiyi B. Evaluation of anti-inflammatory activity of Justicia secunda Vahl leaf extract using in vitro and in vivo inflammation models. Clinical Phytoscience. 2019 Dec;5:1-3.
Singh, S., Ushir, Y. V., & Prajapati, B. (2023). Phytosomes and herbosomes: a vesicular drug delivery system for improving the bioavailability of natural products. In Lipid-Based Drug Delivery Systems (pp. 423-460). Jenny Stanford Publishing.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
